IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,853,573 | -13.4% | 613,749 | 0.0% | 0.12% | -12.6% |
| Q2 2023 | $36,800,390 | +21.3% | 613,749 | 0.0% | 0.14% | +16.4% |
| Q1 2023 | $30,343,750 | -13.4% | 613,749 | 0.0% | 0.12% | -9.4% |
| Q4 2022 | $35,026,655 | -6.2% | 613,749 | -22.9% | 0.13% | -19.0% |
| Q3 2022 | $37,357,000 | +25.8% | 795,849 | 0.0% | 0.16% | +31.7% |
| Q2 2022 | $29,693,000 | +22.8% | 795,849 | -1.6% | 0.12% | +51.9% |
| Q1 2022 | $24,175,000 | +38.5% | 808,549 | +58.6% | 0.08% | +36.2% |
| Q4 2021 | $17,457,000 | +137.9% | 509,856 | +157.5% | 0.06% | +114.8% |
| Q3 2021 | $7,339,000 | – | 197,999 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |